Malignant Neoplasm of Stomach Completed Phase 2 Trials for Leucovorin (DB00650)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00525785Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)Treatment
NCT01246960A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerTreatment
NCT01913639FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric CancerTreatment
NCT01747551FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric CancerTreatment
NCT01715233Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.Treatment
NCT00515411Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaTreatment
NCT00003298Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric CancerTreatment
NCT00002722High-Dose Chemotherapy in Treating Patients With Advanced Stomach CancerTreatment
NCT00002783Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerTreatment
NCT00004233S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or StomachTreatment
NCT00004127Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or StomachTreatment
NCT00003862Chemotherapy and Radiation Therapy in Treating Patients With Stomach CancerTreatment
NCT00006038Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerTreatment
NCT00154778Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric CancerTreatment
NCT00183911Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric AdenocarcinomaTreatment
NCT00210184Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric CancerTreatment
NCT00447967Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsTreatment
NCT00514020Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerTreatment
NCT00737373Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus CancerTreatment
NCT00849615Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionTreatment
NCT01360086Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionTreatment
NCT01590719A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerTreatment
NCT02090153Study of S-1 Plus LV for Advanced Gastric CancerTreatment